Literature DB >> 9240418

Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers.

Y Akiyama1, N Tsubouchi, Y Yuasa.   

Abstract

hMSH3 is one of the human DNA mismatch repair genes but has not yet been reported to be associated with hereditary nonpolyposis colorectal cancer. Recently, somatic mutation at a polyadenine tract, i.e., (A)8, in hMSH3 was reported in cancers with microsatellite instability (MI). To clarify the tumorigenetic role of hMSH3, we screened for somatic mutations at the hMSH3 (A)8 repeat in 29 tumors from 23 hereditary nonpolyposis colorectal cancer patients. One or two A deletions in the (A)8 repeat were found in 11 (57.9%) of the 19 MI-positive tumors but not in 10 MI-negative ones, indicating secondary mutations after germline mutations of other mismatch repair genes. Moreover, the MI frequency of three or more nucleotide repeats was higher in hMSH3 (A)8-mutated tumor cells than in nonmutated ones (p<0.05). These data suggest that a mutation of a mismatch repair gene enhances the frequency of another mismatch repair gene mutation, such as of hMSH3, resulting in severe MI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240418     DOI: 10.1006/bbrc.1997.6942

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer.

Authors:  A Loukola; S Vilkki; J Singh; V Launonen; L A Aaltonen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.

Authors:  C Richard Boland; Minoru Koi; Dong K Chang; John M Carethers
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

3.  Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.

Authors:  Monika Morak; Sarah Käsbauer; Martina Kerscher; Andreas Laner; Anke M Nissen; Anna Benet-Pagès; Hans K Schackert; Gisela Keller; Trisari Massdorf; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 4.  Colorectal cancer: genetics of development and metastasis.

Authors:  Tetsuji Takayama; Koji Miyanishi; Tsuyoshi Hayashi; Yasushi Sato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

Review 5.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

6.  Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Authors:  Alison E Gammie; Naz Erdeniz; Julia Beaver; Barbara Devlin; Afshan Nanji; Mark D Rose
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

Review 7.  A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.

Authors:  Tuya Pal; Jenny Permuth-Wey; Thomas A Sellers
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

8.  Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene.

Authors:  Eva Ripberger; Michael Linnebacher; Yvette Schwitalle; Johannes Gebert; Magnus von Knebel Doeberitz
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

9.  Frameshift mutations and a length polymorphism in the hMSH3 gene and the spectrum of microsatellite instability in sporadic colon cancer.

Authors:  H Orimo; E Nakajima; M Ikejima; M Emi; T Shimada
Journal:  Jpn J Cancer Res       Date:  1999-12

10.  Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation.

Authors:  Manuela Pinheiro; Carla Pinto; Ana Peixoto; Isabel Veiga; Paula Lopes; Rui Henrique; Helena Baldaia; Fátima Carneiro; Raquel Seruca; Ian Tomlinson; Michal Kovac; Karl Heinimann; Manuel R Teixeira
Journal:  Br J Cancer       Date:  2015-08-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.